Indication

Dravet syndrome

Dravet syndrome is a rare, severe developmental and epileptic encephalopathy that typically presents during the first year of life in otherwise developmentally normal infants. Read more about Dravet syndrome

9 drugs 7 manufacturers

Advertisement

Drugs that treat it

Common Dravet syndrome therapies.

Showing 1–9 of 9 drugs

Filter & compare in the drug finder →Opens the drug finder with Dravet syndrome preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Dravet syndrome.

Dravet syndrome is a rare, severe developmental and epileptic encephalopathy that typically presents during the first year of life in otherwise developmentally normal infants.

Affecting the central nervous system, it is predominantly driven by loss-of-function variants in the SCN1A gene, which encodes the alpha-1 subunit of voltage-gated sodium channels critical for inhibitory neuronal function.

The condition is clinically characterized by prolonged, drug-resistant convulsive seizures—often febrile, hemiclonic, or generalized tonic-clonic—with a marked susceptibility to status epilepticus.

As the disease progresses, children often develop diverse seizure types, motor and gait abnormalities, sleep disturbances, and progressive neurodevelopmental delays leading to intellectual disability.

Personalize your experience

Follow Dravet syndrome and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it